The Motley Fool
27 Jun 2026, 17:13 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Clover Health's Q1 revenue increased 62% year-over-year to $749.2 million, with memberships growing 51%. — Strong top-line growth and membership expansion indicate significant scaling and market share gains.
+0.60Clover Health swung from a net loss of $1.3 million in Q1 2025 to a net income of $27.3 million this year. — A transition to profitability is a major valuation catalyst for growth-stage healthcare companies.
+0.50Clover Health won a court case requiring Medicare to upgrade its rating, potentially unlocking additional revenue. — Direct government rating upgrades typically lead to immediate and predictable increases in reimbursement revenue.
+0.40Continue reading
6 related stories
Top 2 movers · tap to explore
Board member Dr. Carladenise Armbrister Edwards sold 67,160 shares of CLOV on May 18, 2026. — Insider selling can be seen as a bearish signal, though the scale relative to her remaining holdings is modest.
Which stocks this story touches
The company reported massive revenue growth, swung to a net profit in Q1, and won a court case that could unlock additional revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
2h ago
